Have your own idea? Try our Stock Screener
Egyptian (CASE/EGX) Healthcare Sector Analysis
UpdatedFeb 08, 2026
DataAggregated Company Financials
Companies17
- 7D4.6%
- 3M1.4%
- 1Y80.1%
- YTD0.2%
The Healthcare industry is up 4.6% in the last week, with Ibnsina Pharma up 15%. In the last 12 months, the industry was up 80%. As for the next few years, earnings are expected to grow by 25% per annum.
Sector Valuation and Performance
Has the Egyptian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 09 Feb 2026 | ج.م94.4b | ج.م115.9b | ج.م5.5b | 17.5x | 17.1x | 0.8x |
| Wed, 07 Jan 2026 | ج.م93.6b | ج.م115.7b | ج.م5.4b | 16.2x | 17.2x | 0.8x |
| Fri, 05 Dec 2025 | ج.م87.6b | ج.م114.4b | ج.م5.2b | 17x | 16.8x | 0.8x |
| Sun, 02 Nov 2025 | ج.م93.3b | ج.م108.4b | ج.م5.1b | 17.8x | 18.2x | 0.9x |
| Tue, 30 Sep 2025 | ج.م80.8b | ج.م108.4b | ج.م5.1b | 15.5x | 15.8x | 0.7x |
| Thu, 28 Aug 2025 | ج.م69.4b | ج.م106.0b | ج.م4.7b | 16.6x | 14.8x | 0.7x |
| Sat, 26 Jul 2025 | ج.م61.4b | ج.م98.5b | ج.م4.3b | 13.2x | 14.2x | 0.6x |
| Mon, 23 Jun 2025 | ج.م54.4b | ج.م98.5b | ج.م4.3b | 11.2x | 12.7x | 0.6x |
| Wed, 21 May 2025 | ج.م56.3b | ج.م95.5b | ج.م3.8b | 9.1x | 14.9x | 0.6x |
| Fri, 18 Apr 2025 | ج.م53.2b | ج.م88.3b | ج.م3.9b | 9.1x | 13.5x | 0.6x |
| Sun, 16 Mar 2025 | ج.م53.8b | ج.م87.7b | ج.م4.0b | 9.5x | 13.5x | 0.6x |
| Tue, 11 Feb 2025 | ج.م48.0b | ج.م78.0b | ج.م3.4b | 17.6x | 14.2x | 0.6x |
| Thu, 09 Jan 2025 | ج.م48.0b | ج.م77.9b | ج.م3.4b | 18.9x | 14.3x | 0.6x |
| Sat, 07 Dec 2024 | ج.م47.8b | ج.م77.4b | ج.م3.2b | 18.1x | 14.8x | 0.6x |
| Mon, 04 Nov 2024 | ج.م46.5b | ج.م69.2b | ج.م2.9b | 9.1x | 16.1x | 0.7x |
| Wed, 02 Oct 2024 | ج.م43.9b | ج.م69.3b | ج.م2.9b | 9.7x | 15.3x | 0.6x |
| Fri, 30 Aug 2024 | ج.م35.4b | ج.م68.9b | ج.م3.1b | 7.9x | 11.4x | 0.5x |
| Sun, 28 Jul 2024 | ج.م34.6b | ج.م63.7b | ج.م3.1b | 7.6x | 11.3x | 0.5x |
| Tue, 25 Jun 2024 | ج.م34.3b | ج.م63.2b | ج.م3.0b | 8.4x | 11.4x | 0.5x |
| Thu, 23 May 2024 | ج.م33.2b | ج.م62.0b | ج.م2.4b | 10.8x | 13.6x | 0.5x |
| Sat, 20 Apr 2024 | ج.م36.6b | ج.م57.5b | ج.م2.4b | 12.2x | 15.5x | 0.6x |
| Mon, 18 Mar 2024 | ج.م37.7b | ج.م57.1b | ج.م2.9b | 10x | 13.1x | 0.7x |
| Wed, 14 Feb 2024 | ج.م37.0b | ج.م52.6b | ج.م3.0b | 10.6x | 12.4x | 0.7x |
| Fri, 12 Jan 2024 | ج.م33.2b | ج.م50.2b | ج.م2.8b | 9.7x | 11.9x | 0.7x |
| Sun, 10 Dec 2023 | ج.م34.6b | ج.م44.2b | ج.م2.7b | 12.1x | 12.7x | 0.8x |
| Tue, 07 Nov 2023 | ج.م27.4b | ج.م45.6b | ج.م2.5b | 10.3x | 10.9x | 0.6x |
| Thu, 05 Oct 2023 | ج.م24.5b | ج.م45.5b | ج.م2.5b | 9.4x | 9.9x | 0.5x |
| Sat, 02 Sep 2023 | ج.م24.7b | ج.م45.9b | ج.م2.6b | 10x | 9.6x | 0.5x |
| Mon, 31 Jul 2023 | ج.م24.5b | ج.م42.7b | ج.م2.6b | 9.8x | 9.5x | 0.6x |
| Wed, 28 Jun 2023 | ج.م26.2b | ج.م43.1b | ج.م2.7b | 9.2x | 9.7x | 0.6x |
| Fri, 26 May 2023 | ج.م25.9b | ج.م41.6b | ج.م2.9b | 9.1x | 9.1x | 0.6x |
| Sun, 23 Apr 2023 | ج.م25.6b | ج.م41.6b | ج.م2.9b | 8.5x | 8.9x | 0.6x |
| Tue, 21 Mar 2023 | ج.م24.7b | ج.م41.1b | ج.م2.8b | 7.9x | 8.7x | 0.6x |
| Thu, 16 Feb 2023 | ج.م27.8b | ج.م40.5b | ج.م2.8b | 10x | 9.8x | 0.7x |
Price to Earnings Ratio
9.8x
Current Industry PE
- Investors are optimistic on the Egyptian Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 17.1x which is higher than its 3-year average PE of 12.8x.
- The industry is trading close to its 3-year average PS ratio of 0.63x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 25% per year over the last three years.
- Revenues for these companies have grown 42% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Egyptian Healthcare sector?
| EG Market | 2.70% | |
| Healthcare | 4.56% | |
| Pharma | 5.20% | |
| Healthcare Services | 3.75% | |
Industry PE
- Investors are most optimistic about the Healthcare Services industry, which is trading close to its 3-year average PE ratio of 24.0x.
- Analysts are expecting annual earnings growth of 26.5%, which is lower than the prior year's growth of 71.8% per year.
- Investors are most pessimistic about the Pharma industry, although it looks like investor sentiment has improved given that it's trading above its 3-year average of 9.3x.
Forecasted Growth
- Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 26% over the next 5 years.
- However this is lower than its past earnings growth rate of 72% per year.
- In contrast, the Pharma industry is expected to see its earnings grow by 23% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ISPH Ibnsina Pharma | ج.م12.63 | 14.1% +ج.م1.6b | 95.8% | PE18.1x | |
| PHAR Egyptian International Pharmaceutical Industries | ج.م85.50 | 7.6% +ج.م1.0b | 90.4% | PE11.5x | |
| RMDA Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) | ج.م3.52 | 10.7% +ج.م680.0m | 30.5% | PE17.7x | |
| NIPH EI- Nile for Pharmaceuticals and Chemical Industries | ج.م106.12 | 9.4% +ج.م454.0m | 103.8% | PE21.7x | |
| BIOC GlaxoSmithKlineE | ج.م68.43 | 5.2% +ج.م283.9m | 80.8% | PE58.1x |